搜尋結果
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug
Reuters· 1 日前A panel of outside experts to the U.S. health regulator will vote on Monday on whether data for ...
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
Bloomberg· 1 日前US drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s ...
AbbVie's ovarian cancer therapy succeeds in mid-stage trial
Reuters· 1 日前The therapy, Elahere, was being tested in patients with a type of cancer that affects the ...
Why Prescription Drug Prices in the US Are So High
Bloomberg· 1 日前Americans spend more on prescription drugs than anyone else in the world. Unlike in most other ...
Cheaper Ozempic Alternatives Are Out There. Be Wary of Fakes and Fraudsters.
The Wall Street Journal· 1 日前Millions of people are taking Ozempic, Wegovy or Mounjaro for weight loss. Compounded drugs are ...
Bloomberg Talks: Lars Fruergaard Jørgensen - Bloomberg
Bloomberg· 1 日前Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest ...
Stocks making the biggest moves before the bell: Robinhood, Nvidia, Lululemon, Five Below and more
CNBC· 1 日前The online brokerage rose more than 3% after revealing a $200 million deal to purchase crypto ...
Nestle's health arm to buy first-ever fecal transplant pill
Reuters· 2 日前, opens new tab Vowst, the companies said on Thursday, gaining access to the first ever pill alternative to fecal transplants ...
Move over 'Magnificent 7,' the 'Fantastic 5' may offer higher earnings and ...
CNBC· 2 日前Looking for a less risky way to find growth stocks amid all the artificial intelligence hype? ...
Nation's reform efforts hailed by execs, experts
China Daily· 2 日前China's recent move to deepen economic structural reform is an attempt to cultivate new quality productive forces and foster ...